全球ATP检测市场

预计到 2030 年全球 ATP 检测市场规模将达到 5.456 亿美元

全球ATP检测市场规模预计在2024年为3.615亿美元，到2030年将达到5.456亿美元，在2024-2030年的分析期间内，复合年增长率为7.1%。报告分析的细分市场之一——耗材及配件——预计复合年增长率为6.9%，到分析期结束时达到4.87亿美元。设备细分市场在分析期间内的复合年增长率预计为9.1%。

美国市场规模估计为 9,370 万美元，中国市场预计复合年增长率为 10.9%

预计到2024年，美国ATP检测市场规模将达到9,370万美元。作为世界第二大经济体，中国市场规模预计到2030年将达到1.344亿美元，在2024-2030年的分析期间内，复合年增长率为10.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为3.2%和6.3%。在欧洲，预计德国市场的复合年增长率为4.0%。

全球 ATP 检测市场—主要趋势和驱动因素摘要

什么是 ATP 检测？

ATP 测定是一种专门的生化技术，用于测量样本中三Adenosine(ATP) 的浓度，提供有关细胞能量和活力的宝贵资讯。 ATP 也被称为细胞的“能量货币”，支持许多生命所必需的细胞功能，从蛋白质合成到肌肉收缩再到细胞分裂。 ATP 测定利用 ATP 与萤光素酶相互作用时所发生的生化反应。在该反应中，ATP 在萤光素酶存在下作为基材，萤光素酶与氧气反应产生光（冷光）。光的强度与样品中存在的 ATP 含量直接相关，透过使用光度计检测这种光，研究人员可以非常准确地量化 ATP 水平。这种高灵敏度使 ATP 测定能够测量即使是微量的 ATP，这使其在细胞活性低或微生物污染低的样本中特别有用。由于ATP生成是细胞活力和代谢活跃的标誌，此检测方法可作为细胞健康状况的通用指标，使研究人员能够即时评估细胞活力、微生物污染和代谢活动。 ATP检测方法简单、灵敏且功能多样，使其成为微生物学、细胞生物学、药理学和环境科学等需要了解细胞能量动力学的领域中不可或缺的工具。

ATP 检测与其他细胞活力测试有何不同？

ATP 检测因其高灵敏度、快速结果以及直接测量细胞能量状态的能力而在其他细胞活力检测中脱颖而出。与 MTT 和 XTT 等依赖代谢反应且需要较长孵育时间的比色检测不同，ATP 检测在添加萤光素酶试剂后几乎可以立即提供结果，使其成为速度要求极高的高通量筛检应用的理想选择。 ATP 检测的独特优势在于它直接测量 ATP，这是一种存在于所有活细胞中的通用能量分子。其他检测方法通常依赖细胞代谢物，而这些代谢物可能会因细胞类型、状态以及实验设计的不同而变化，导致结果不一致。此外，ATP 检测灵敏度高，能够检测飞摩尔级的 ATP，因此可用于检测微量细菌和真菌污染。这种灵敏度和适应性使 ATP 检测在临床诊断（用于筛检患者样本中的微生物污染）以及环境监测和药物检测（准确的细胞活力数据至关重要）中尤为重要。 ATP 检测的简单性，加上快速、灵敏和多功能的细胞活力测量方法，巩固了其作为研究和工业领域首选技术的地位。

ATP 检测对研究和产业有何影响？

ATP 检测已成为科学研究和工业生产中的重要工具，对微生物学、环境监测和药物开发等领域产生了深远的影响。在微生物学和临床诊断领域，ATP 检测因其快速的检测能力而常用于检测微生物污染。这种快速的检测速度在食品安全检测中至关重要，食品和饮料产业依赖 ATP 检测来确保加工和生产环境不受微生物污染。在细胞生物学和药理学领域，ATP 检测使研究人员能够研究药物、毒素和环境压力对细胞健康和代谢活动的影响。 ATP 定量分析使科学家能够直接评估细胞对治疗的反应。这在药物研发中尤其有用，因为快速筛检具有细胞毒性的化合物至关重要。 ATP 检测对 ATP 水平变化的敏感性也使其在研究影响能量代谢的疾病（例如癌症、粒线体疾病和代谢疾病）中发挥重要作用。在製药和生物技术产业，ATP 检测对于高通量筛检至关重要，因为高通量筛选需要测试数千种化合物对细胞活力和 ATP 生成的影响。这个筛检过程能够快速可靠地辨识有潜力的候选药物，加速药物研发。 ATP 检测在多个学科领域的广泛应用反映了其在测量细胞健康、确保微生物安全以及支持精准高效疗法开发方面的实用性。

是什么推动了 ATP 检测需求的成长？

ATP 检测市场的成长受到多种因素的推动，包括检测灵敏度的提高、对快速可靠细胞活力检测日益增长的需求，以及在临床诊断、环境监测和生物製药研究中不断扩展的应用。技术进步显着提高了 ATP 检测的灵敏度、速度和易用性，使其更加普及，并使实验室能够进行更有效率、更准确的检测。光度计技术的进步和检测试剂的改进使 ATP 检测能够检测到极低浓度的 ATP，从而有利于其在需要极高精度测量的领域中的应用，例如对水和土壤样本中微量微生物污染的环境监测。对生物製药的日益关注也推动了药物筛检和细胞治疗研究中对 ATP 检测的需求，在这些研究中，对细胞活力和代谢活动的评估至关重要。随着细胞疗法和个人化医疗的持续发展，对 ATP 检测等高灵敏度即时检测的需求也日益增长。在临床诊断中，ATP 检测在评估与代谢改变相关的疾病（例如癌症和粒线体疾病）中的细胞能量水平方面发挥关键作用。此外，将 ATP 检测整合到高通量筛检平台中，可以快速且经济高效地测试大型化合物库，使其在药物开发中的价值日益提升。近年来，这种高通量能力支撑了药物开发和测试的加速。 ATP 检测的应用范围不断扩大，加上其灵敏度、多功能性以及与产业格局的契合度，预计将推动科学和产业的持续成长和整合。

部分

组件（耗材及配件、设备）、应用（污染检测、疾病检测、药物研发）、最终用途（製药和生物技术公司、食品和饮料、医院和诊断实验室、学术和研究机构）

受访公司范例

• 3M Company
• AAT Bioquest, Inc.
• Abcam PLC.
• Abnova Corporation
• Agilent Technologies, Inc.
• BioThema AB
• Biotium
• BioVision, Inc.
• Canvax Biotech SL
• Creative Bioarray

人工智慧集成

全球产业分析师正在利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 并未遵循典型的 LLM 或特定产业的 SLM查询，而是建立了一个从全球专家收集的内容库，其中包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global ATP Assay Market to Reach US$545.6 Million by 2030

The global market for ATP Assay estimated at US$361.5 Million in the year 2024, is expected to reach US$545.6 Million by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$487.0 Million by the end of the analysis period. Growth in the Instruments segment is estimated at 9.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$93.7 Million While China is Forecast to Grow at 10.9% CAGR

The ATP Assay market in the U.S. is estimated at US$93.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$134.4 Million by the year 2030 trailing a CAGR of 10.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.2% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global ATP Assay Market - Key Trends and Drivers Summarized

What Is an ATP Assay and How Does It Work?

An ATP assay is a specialized biochemical technique used to measure the concentration of adenosine triphosphate (ATP) in a sample, providing valuable information about cellular energy and viability. ATP, often described as the “energy currency” of the cell, powers numerous cellular functions essential for life, from protein synthesis to muscle contraction and cell division. The ATP assay leverages the biochemical reaction that occurs when ATP interacts with the enzyme luciferase. In this reaction, ATP is used as a substrate in the presence of luciferase, where it reacts with oxygen and emits light (luminescence) as a byproduct. The intensity of this luminescence directly corresponds to the amount of ATP present in the sample, and by using a luminometer to detect this light, researchers can quantify ATP levels with great accuracy. This high sensitivity allows ATP assays to measure even trace amounts of ATP, which is particularly useful in samples where cellular activity is low or microbial contamination is minimal. Because ATP production is a hallmark of viable, metabolically active cells, this assay serves as a universal indicator of cell health, allowing researchers to assess cell viability, microbial contamination, or metabolic activity in real time. The simplicity, sensitivity, and versatility of the ATP assay make it an indispensable tool across fields such as microbiology, cellular biology, pharmacology, and environmental science, where understanding cellular energy dynamics is essential.

What Distinguishes ATP Assays from Other Cell Viability Tests?

ATP assays stand out from other cell viability tests due to their high sensitivity, rapid results, and ability to provide a direct measure of cellular energy status. Unlike colorimetric assays such as MTT or XTT, which rely on metabolic reactions and require longer incubation times, ATP assays can produce results almost instantly after the addition of the luciferase reagent, making them ideal for high-throughput screening applications where speed is critical. The ATP assay is uniquely advantageous because it directly measures ATP, a universal energy molecule found in all living cells, meaning it can be applied to a wide range of cell types and biological conditions without bias. Other assays often rely on cellular metabolites that can vary by cell type, condition, or experimental design, potentially introducing variability into results. Additionally, ATP assays are exceptionally sensitive and can detect ATP in the femtomole range, making them useful for detecting even trace levels of bacterial or fungal contamination. This level of sensitivity and adaptability has made ATP assays particularly valuable in clinical diagnostics, where they are used to screen for microbial contamination in patient samples, as well as in environmental monitoring and pharmaceutical testing, where precise cell viability data are critical. The simplicity of the ATP assay, combined with its rapid, highly sensitive, and versatile approach to cell viability measurement, has solidified its position as a preferred technique in both research and industry.

How Have ATP Assays Impacted Research and Industry?

ATP assays have become essential tools in scientific research and industry, profoundly impacting fields such as microbiology, environmental monitoring, and drug development. In microbiology and clinical diagnostics, ATP assays are frequently used to detect microbial contamination due to their rapid detection capabilities, which can reveal contamination within minutes rather than the hours or days required by traditional culture methods. This speed is invaluable in food safety testing, where the food and beverage industry relies on ATP assays to ensure that processing and manufacturing environments remain free of microbial contaminants. In cellular biology and pharmacology, ATP assays enable researchers to measure the effects of drugs, toxins, or environmental stressors on cellular health and metabolic activity. By quantifying ATP, scientists can directly assess cellular responses to treatments, which is particularly useful in drug discovery, where rapid screening of compounds for cytotoxicity is critical. The ATP assay’s sensitivity to changes in ATP levels also makes it valuable for studying conditions that affect energy metabolism, such as cancer, mitochondrial disorders, and metabolic diseases. In the pharmaceutical and biotechnology industries, ATP assays are essential for high-throughput screening, where thousands of compounds are tested to determine their effects on cell viability and ATP production. This screening process accelerates drug discovery by enabling quick, reliable identification of promising drug candidates. The widespread adoption of ATP assays across diverse sectors reflects their utility in measuring cellular health, ensuring microbial safety, and supporting the development of therapeutic agents with high precision and efficiency.

What Drives the Growing Demand for ATP Assays?

The growth in the ATP assay market is driven by multiple factors, including advancements in assay sensitivity, the increasing need for rapid and reliable cell viability testing, and the expanding applications in clinical diagnostics, environmental monitoring, and biopharmaceutical research. Technological advancements have significantly enhanced the sensitivity, speed, and ease of use of ATP assays, making them more accessible and allowing laboratories to conduct assays with greater efficiency and accuracy. New developments in luminometer technology, as well as improvements in assay reagents, have enabled ATP assays to detect even the smallest ATP concentrations, facilitating their use in fields that require extremely precise measurements, such as environmental monitoring for trace microbial contamination in water and soil samples. The growing focus on biopharmaceuticals has also driven demand for ATP assays in drug screening and cell-based therapy research, where assessing cell viability and metabolic activity is essential. As cell-based therapies and personalized medicine continue to rise, the demand for highly sensitive, real-time assays like ATP tests is only expected to increase. In clinical diagnostics, ATP assays play a vital role in assessing cellular energy levels in diseases linked to altered metabolism, such as cancer and mitochondrial disorders. Additionally, the integration of ATP assays into high-throughput screening platforms has become increasingly valuable in pharmaceutical development, as it allows for rapid, cost-effective testing of large compound libraries. This high-throughput capability has supported the accelerated pace of drug development and testing in recent years. The expanding applications, combined with the assay’s sensitivity, versatility, and alignment with industry trends, are positioning ATP assays for continued growth and integration across scientific and industrial landscapes.

SCOPE OF STUDY:

The report analyzes the ATP Assay market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Consumables & Accessories, Instruments); Application (Contamination Testing, Disease Testing, Drug Discovery & Development); End-Use (Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories, Academic & Research Institutions)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 19 Featured) -

• 3M Company
• AAT Bioquest, Inc.
• Abcam PLC.
• Abnova Corporation
• Agilent Technologies, Inc.
• BioThema AB
• Biotium
• BioVision, Inc.
• Canvax Biotech S.L.
• Creative Bioarray

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • ATP Assay - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Demand for Rapid and Accurate Microbial Detection Drives Growth in ATP Assay Market
  • Increasing Focus on Food Safety Testing Expands Use of ATP Assays in Quality Control
  • Here's How Advances in Bioluminescence Technology Enhance Sensitivity in ATP Assays
  • Rising Applications of ATP Assays in Clinical Diagnostics Fuel Market Expansion
  • Growing Use of ATP Assays in Environmental Monitoring Supports Demand for Real-Time Testing
  • Advancements in Portable and Handheld ATP Testing Devices Boost Field Testing Applications
  • Here's How the Pharmaceutical Industry's Focus on Sterility Testing Drives ATP Assay Adoption
  • Increasing Adoption of ATP Assays in Water Quality Monitoring Expands Market Scope
  • Focus on Reducing Testing Time and Enhancing Workflow Efficiency Fuels ATP Assay Innovation
  • Growing Use of ATP Assays in Biopharmaceutical Production Ensures Quality and Safety
  • Here's How Rising Interest in Personalized Medicine Drives ATP Assay Applications in Cell Viability Testing
  • Increasing Focus on Hospital Infection Control Expands Applications of ATP Assays in Healthcare
  • Growing Demand for Sensitive and Non-Invasive Testing Methods Fuels ATP Assay Development
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for ATP Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for ATP Assay by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for ATP Assay by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Consumables & Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Consumables & Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Contamination Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Contamination Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Contamination Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for Disease Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for Disease Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Drug Discovery & Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Drug Discovery & Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Food & Beverage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Food & Beverage by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Food & Beverage by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Hospitals & Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Hospitals & Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Academic & Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Academic & Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Academic & Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World ATP Assay Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 32: USA Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: USA 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 35: USA Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 41: Canada Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: Canada Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: Canada 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 44: Canada Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: Canada 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• JAPAN
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 50: Japan Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Japan Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Japan 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 53: Japan Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Japan 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• CHINA
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 59: China Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: China Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: China 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 62: China Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• EUROPE
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for ATP Assay by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for ATP Assay by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for ATP Assay by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• FRANCE
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 80: France Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 83: France Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: France 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: France 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• GERMANY
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 89: Germany Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Germany Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Germany 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 92: Germany Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Germany 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: Germany 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 98: Italy Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Italy Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Italy 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 101: Italy Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Italy 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Italy 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 107: UK Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: UK Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: UK 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 110: UK Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: UK 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: UK 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 116: Spain Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Spain Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Spain 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 119: Spain Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Spain 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: Spain 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 125: Russia Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Russia Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Russia 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 128: Russia Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Russia 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Russia 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Rest of Europe Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Rest of Europe 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for ATP Assay by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 144: Asia-Pacific Historic Review for ATP Assay by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Asia-Pacific 15-Year Perspective for ATP Assay by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• AUSTRALIA
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 155: Australia Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Australia Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Australia 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 158: Australia Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Australia 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Australia 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• INDIA
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 164: India Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: India Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: India 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 167: India Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: India 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: India 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 173: South Korea Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: South Korea Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: South Korea 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: South Korea 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: South Korea 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Asia-Pacific Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Asia-Pacific 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 191: Latin America Recent Past, Current & Future Analysis for ATP Assay by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 192: Latin America Historic Review for ATP Assay by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Latin America 15-Year Perspective for ATP Assay by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Latin America 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Latin America 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 203: Argentina Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Argentina Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Argentina 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Argentina 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Argentina 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 212: Brazil Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Brazil Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Brazil 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Brazil 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Brazil 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 221: Mexico Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Mexico Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Mexico 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Mexico 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Mexico 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Rest of Latin America Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Rest of Latin America 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 239: Middle East Recent Past, Current & Future Analysis for ATP Assay by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 240: Middle East Historic Review for ATP Assay by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Middle East 15-Year Perspective for ATP Assay by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Middle East 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Middle East 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 251: Iran Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Iran Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Iran 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 254: Iran Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Iran 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Iran 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 260: Israel Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Israel Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Israel 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 263: Israel Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Israel 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Israel 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Saudi Arabia Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Saudi Arabia 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 278: UAE Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: UAE Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: UAE 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 281: UAE Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: UAE 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: UAE 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Rest of Middle East Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Rest of Middle East 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030
• AFRICA
  • ATP Assay Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 296: Africa Recent Past, Current & Future Analysis for ATP Assay by Component - Consumables & Accessories and Instruments - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Africa Historic Review for ATP Assay by Component - Consumables & Accessories and Instruments Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Africa 15-Year Perspective for ATP Assay by Component - Percentage Breakdown of Value Sales for Consumables & Accessories and Instruments for the Years 2015, 2025 & 2030
  • TABLE 299: Africa Recent Past, Current & Future Analysis for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for ATP Assay by Application - Contamination Testing, Disease Testing and Drug Discovery & Development Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Africa 15-Year Perspective for ATP Assay by Application - Percentage Breakdown of Value Sales for Contamination Testing, Disease Testing and Drug Discovery & Development for the Years 2015, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for ATP Assay by End-Use - Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Africa 15-Year Perspective for ATP Assay by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Food & Beverage, Hospitals & Diagnostic Laboratories and Academic & Research Institutions for the Years 2015, 2025 & 2030

IV. COMPETITION